New scan could spot hidden prostate cancer spread
NCT ID NCT05520255
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 3 study is testing a radioactive tracer called 18F-PSMA-1007 for PET/CT scans in 2800 men with prostate cancer. The goal is to see if it can safely and accurately detect cancer that has spread, especially in men with rising PSA levels after treatment. Participants will be monitored for side effects right after injection and up to a week later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-PSMA-1007 (a radioactive tracer for PET/CT imaging)
What this could lead to
If successful, this could give doctors a more accurate way to see where prostate cancer has spread, helping guide treatment decisions.
What could go wrong
This is still an investigational tracer, and the study focuses on imaging accuracy and safety, not treatment. It may not prove better than existing scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alberta
RECRUITINGEdmonton, Alberta, T6G 2R3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••